Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

In the assessment of 12-month price targets, analysts unveil insights for Tempus AI, presenting an average target of $64.09, ...

Boehringer will gain access to the de-identified database of Tempus, which comprises clinical, imaging and molecular data.

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

The Chicago-based Tempus spinout called the financing round a major milestone as it expands its AI-enabled platform.

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

The prize is better outcomes, but the price may be sharing more personal details. Lawyers are working on the new rules ...

Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

If watchmaking had a Daft Punk, it would be Bruno Belamich and Carlos Rosillo. They met as students, made their debut from ...